XtalPi and Baicheng Medicine Announce Strategic Collaboration to Advance Innovative Drug Development

XtalPi Leadership Visits China Merchants Group to Explore Strategic Collaboration in AI-Driven Innovation

XtalPi Announces Milestone Achievement in Collaboration with PharmaEngine on Next-Generation PRMT5 Inhibitor PEP08

Signet Therapeutics, Incubated by XtalPi, Nominated for 2025 Prix Galien USA Best Biotechnology Award for First-in-Class Diffuse Gastric Cancer Drug SIGX1094R

XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

XtalPi Innovation Center and JingJiaHang BioPharma Announce Strategic Collaboration to Advance AI-Driven Radionuclide Drug Development

XtalPi’s “New Paradigm in Synthetic Chemistry: AI and Robotics Symposium” Concludes Successfully

XtalPi Opens AI Drug Discovery Platform to Faculty and Students at China Pharmaceutical University

Using AI to Spread Love: XtalPi’s Children’s Poetry and Art Charity Initiative

XtalPi’s Intelligent Autonomous Lab Solution Platform Drives Multi-Industry Innovation

XtalPi and PaiLin Bio Join Forces to Empower Specialized Biopharma with AI Technology